The COVID-19 epidemic has spread rapidly worldwide. It can cause severe lung disease and multiple organ damage. The support of vulnerable individuals during the CIVID-19 pandemic includes those with congenital or acquired immune-depression. Due to long-term use of oral immunosuppressive drugs and associated comorbidities, it is admitted that liver transplant recipients are suspected to be more susceptible to COVID-19 infection and have a worse prognosis than the general population. In this report, we describe two cases of liver transplant recipient with COVID-19 infection. We also reviewed some literature about the characteristics and management of COVID-19 in liver transplant patients.
Select your language of interest to view the total content in your interested language
Annals of Medical and Health Sciences Research received 20588 citations as per google scholar report
The Annals of Medical and Health Sciences Research is a bi-monthly multidisciplinary medical journal.